BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 9458646)

  • 1. [Hemophiliacs with HIV. Slower progression of the infection among younger patients and at higher dosages of factor concentrates].
    Astermark J; Berntorp E; Stigendal L; Johnsson H
    Lakartidningen; 1998 Jan; 95(1-2):48-50. PubMed ID: 9458646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Progression to AIDS among HIV-seropositive hemophiliacs].
    Lorenzo JI; Molina R; Senent ML; Monzó E; Lerma MA; Dasí MA; Monteagudo E; Aznar JA
    Sangre (Barc); 1992 Jun; 37(3):169-74. PubMed ID: 1440093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with progression to AIDS and mortality in a cohort of HIV-infected patients with hemophilia followed up since seroconversion.
    Santagostino E; Gringeri A; Cultraro D; Tradati F; Siracusano L; Marinoni A; Mannucci PM
    Cell Mol Biol (Noisy-le-grand); 1995 May; 41(3):371-80. PubMed ID: 7580830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression to acquired immunodeficiency syndrome in 94 human immunodeficiency virus-positive hemophiliacs with long-term follow-up.
    Lorenzo JI; Moscardó F; López-Aldeguer J; Aznar JA
    Haematologica; 2001 Mar; 86(3):291-6. PubMed ID: 11357820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical factors associated with progression to AIDS in the Italian cohort of HIV-positive hemophiliacs. G.I.C.C. Gruppo Italiano Coagulopatie Congenite.
    Schinaia N; Ghirardini AM; Mazzucconi MG; Tagariello G; Morfini M; Chiarotti F
    Thromb Haemost; 1994 Jul; 72(1):33-8. PubMed ID: 7974372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-disease progression in Swedish haemophiliacs and the influence of replacement therapy.
    Astermark J; Johnsson H; Stigendal L; Lethagen S; Berntorp E
    Haemophilia; 1997 Oct; 3(4):277-82. PubMed ID: 27214864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+ counts before and after switching to monoclonal high-purity factor VIII concentrate in HIV-infected haemophilic patients.
    Sabin C; Pasi J; Phillips A; Elford J; Janossy G; Lee C
    Thromb Haemost; 1994 Aug; 72(2):214-7. PubMed ID: 7831654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression to AIDS in relation to clinical factors and clotting product consumption. A 14-year follow-up of a cohort of 52 Dutch HIV-1-infected haemophilic patients.
    Roosendaal G; van der Schouw Y; Mauser-Bunschoten E; Borleffs J; van den Berg H
    Vox Sang; 1998; 75(4):261-6. PubMed ID: 9873260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4 cells in HIV-1 infected hemophiliacs: effect of factor VIII concentrates.
    Goldsmith JM; Deutsche J; Tang M; Green D
    Thromb Haemost; 1991 Oct; 66(4):415-9. PubMed ID: 1839091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central venous access catheters in children with haemophilia.
    Blanchette VS; al-Musa A; Stain AM; Filler RM; Ingram J
    Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S39-44. PubMed ID: 8735796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of transfusion-associated virus infections in hemophilic patients needing replacement therapy].
    Meili EO
    Beitr Infusionsther; 1989; 24():46-55. PubMed ID: 2481548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, immunological, and virological aspects in Japanese hemophiliacs and AIDS patients.
    Abe T
    AIDS Res; 1986 Dec; 2 Suppl 1():S141-6. PubMed ID: 3103637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of factor VIII concentrates of very high purity on CD4+ cell count in hemophiliacs infected with HIV].
    Molina Alejandro R; Lorenzo Herrero JI; Haya Guaita S; Querol Fuentes F; Aznar Lucea JA
    Rev Clin Esp; 1996 Jun; 196(6):365-9. PubMed ID: 8767071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Human immunodeficiency virus infection in hemophiliacs: prevalence and current clinical situation].
    Lorenzo JI; Molina R; Arilla MJ; Dasí MA; Monteagudo E; Aznar JA
    Sangre (Barc); 1991 Dec; 36(6):451-5. PubMed ID: 1812578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV infection and AIDS.
    Lloyd A
    P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemophilia and HTLV-III infection].
    Lechler E
    Z Hautkr; 1986 Dec; 61(23):1687-704. PubMed ID: 2949442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell alterations in hemophiliacs treated with commercial clotting factor concentrates.
    Lechner K; Niessner H; Bettelheim P; Deutsch E; Fasching I; Fuhrmann M; Hinterberger W; Korninger C; Neumann E; Liszka K
    Thromb Haemost; 1983 Aug; 50(2):552-6. PubMed ID: 6314582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV infection/acquired immunodeficiency syndrome at Siriraj Hospital, 2002: time for secondary prevention.
    Anekthananon T; Ratanasuwan W; Techasathit W; Rongrungruang Y; Suwanagool S
    J Med Assoc Thai; 2004 Feb; 87(2):173-9. PubMed ID: 15061301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological status and HIV antibodies in patients with haemophilia--a longitudinal study.
    Fuchs D; Hausen A; Reibnegger G; Werner ER; Vinazzer H; Dierich MP; Wachter H
    Wien Klin Wochenschr; 1988 Aug; 100(15):505-9. PubMed ID: 3140497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of HIV-HCV co-infection in a large cohort of hemophiliac patients.
    Lichterfeld M; Schmeisser N; Qurishi N; Vogel M; Brackmann HH; Spengler U; Rockstroh JK
    J Infect; 2005 Apr; 50(3):221-8. PubMed ID: 15780416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.